A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis
Condition: Herpes Simplex Virus Keratitis Interventions: Drug: oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily; Drug: oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops Sponsor: New York University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2018 Category: Research Source Type: clinical trials
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Conditions: Glioblastoma Multiforme; Astrocytoma, Grade III Intervention: Drug: ADV/HSV-tk (gene therapy) Sponsors: David Baskin MD; Center for Cell and Gene Therapy, Baylor College of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2018 Category: Research Source Type: clinical trials
